L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Revenue

L&K Biomed had revenue of 11.74B KRW in the quarter ending June 30, 2026, with 3.67% growth. This brings the company's total for the last twelve months to 39.94B, down -0.11% year-over-year. In the year 2025, L&K Biomed had annual revenue of 38.92B with 7.84% growth. That makes L&K Biomed the 31,294th largest company in the world by revenue and 1,975th in South Korea.

• Revenue (ttm): 39.94B
• Revenue Growth: -0.11%
• P/S Ratio: 3.97
• Revenue / Employee: 380.40M
• Employees: 105
• Market Cap: 158.69B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• USA 26.18B 67.3%
• Other 6.12B 15.7%
• Thailand 5.55B 14.3%
• South Korea 1.07B 2.7%

Fiscal year ended Dec 31, 2025 See the full L&K Biomed breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.92B	2.83B	7.84%
Dec 31, 2024	36.09B	6.19B	20.69%
Dec 31, 2023	29.90B	10.14B	51.28%
Dec 31, 2022	19.77B	4.39B	28.59%
Dec 31, 2021	15.37B	-3.98B	-20.58%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error